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Abstract 
Cancer is the second most common cause of death in the United States, leading to over 
$440 million in annual funding for research and yet anticancer drug development is an 
unmet need. In order to find a more effective way to prevent, detect and treat this disease, 
new cancer therapies are studied. Human Umbilical Cords (HUC) have been used as a 
scaffold in various tissue engineering approaches including tissue engineered blood 
vessels, tissue engineered tendons among many. The decellularized HUCs have been 
shown to support the growth of a variety of cell types including mesenchymal stem cells, 
smooth muscle cells, endothelial cells. To have a complete 3D in-vitro model for cancer 
research, it is necessary to seed and grow tumor cells on the outside part of the cords 
called the Wharton’s jelly. This work attempts to show if cancer cells can attach and 
proliferate on the Wharton’s jelly side of the decellularized and non-decellularized 
(ideally fresh but 5 days old cords in this study) HUC. Two different types of cancer have 
been tested in this project: Breast and Prostate cancer. Two main hypothesis have been 
tested; first, that the cancer cells would adhere and proliferate to the decellularized 
Wharton’s jelly of the HUC and second, that the cancer cells would adhere and proliferate 
to the non-decellularized Wharton’s jelly of the HUC.  
DNA assays have been performed at specific point time (6 hours, Day 2, 6 and 10) to 
observe the cellularity of the different constructs and histology images have been 
recorded to examine their tissue structures. The decellularized Wharton’s jelly of the 
HUC has not shown conclusive results due to a potential contamination during the 
decellularization protocol. On the other hand, the attachment on non-decellularized 
xiii 
constructs shows promising results, especially with the study using the prostate cancer 
cell line. Further analysis is needed to confirm those results. 
 
1 
1. Introduction  
 Cancer 
One in every four deaths in the United States is due to cancer-related diseases, which 
place cancer as the major cause of death worldwide [1]. The invasive potential from a 
normal growth control characterized the main issue of cancer research on the cellular 
level. Close interactions with the surrounding environment, like cells, are maintained by 
the malignant cells during the cancer progression and metastasis previously described 
(Fig.1). The tumor complex environment comprises numerous stromal cells, including 
endothelial cells of the blood and lymphatic circulation, stromal fibroblasts and innate 
and adaptive infiltrating immune cells [2]. These environmental components collectively 
contribute to the tumor-stromal interaction and tumor progression. Cells bind to the 
components of the stromal ECM such as collagen, glycosaminoglycans and 
proteoglycans with the help of a dynamic growth factor-mediated tumor-stromal cell 
crosstalk [3] and integrin-mediated tumor-ECM interactions [4]. This induces a 
metastatic process or a cell migration through a vastly different microenvironment from 
the stroma, to the blood vessel endothelium, to the vascular system to finally reach tissues 
as a secondary site [5], leading to the progression of the disease. 
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Figure 1: Schematic illustration of a typical tumor microenvironment [6]. 
A complex microenvironment surrounds the cancer cells, which contributes to the 
tumor-stromal interaction and tumor progression 
 
 Existing therapy 
According to the National Cancer Institute (NCI), there are as many types of cancer 
treatment as types of cancers. 
 Surgery 
Surgery to treat cancer is used to remove the tumor, but sometimes some healthy tissue 
and their surroundings are also removed, depending on cancer type and potential side 
effects. There are three main stages during which this treatment can be selected. First 
when the surgeon oncologist needs to remove a partial or total tumor in order to identify 
or observe more precisely the stage of the tumor. It is often coupled with staging to figure 
the size and spread of the tumor. From there the decision of removing the tumor 
completely or partially (debulking) is considered and most of the time induce the removal 
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of some healthy surrounding tissue called margin. In order to minimalize side effects, 
palliative surgery can be considered for improving quality of life for patients [7]. After 
any type of cancer treatment, a reconstruction surgery might be considered to reconstruct 
or restore the appearance and function of the previous cancer location. Other type of 
therapy like radiation or chemotherapy (described in section §1.2.2 and §1.2.3) can be 
combined with this technique. 
 Radiation  
Radiation therapy uses high radiation to destroy the cancer cells in the human body [8]. 
Two types of radiation can be used to treat cancer: an internal or external beam. The 
external beam radiation therapy to treat cancer is focused on one specific location of the 
human body and focuses on sending radiation from many directions to this specific site. 
The internal beam radiation is inserted in the human body via solid, brachytherapy, or 
liquid phase via intravenous delivery. The phases focus on damaging the DNA of cancer 
cells to stop their cellular division [9]. 
 Chemotherapy 
Chemotherapy is the use of drugs to kill cancer [8]. This technique is often used in 
combination with other treatment to reduce the size of the tumor before surgery or destroy 
remaining cancer cells after treatment or destroy recurrent cancer cells.  
 Immunotherapy and vaccines 
Immunotherapy consists of using biomaterials substances to help the human immune 
system fight cancer as the regular immune system would fight infections or other disease. 
This treatment focus on targeting the cancer cells with markers to be able to detect them. 
Monoclonal antibodies, cytokines or vaccines are examples of markers [10]. 
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 Targeted therapy 
Targeted therapy uses the changes in cancer cell to detect their presence and target them. 
This technique is like immunotherapy because it is targeting specific cancer cells to mark 
and destroy them with the use of small molecule drugs or monoclonal antibodies [11]. 
This therapy targets the cancer cells but also their surroundings in order to stop them from 
growing and signaling by interfering in the cellular process. 
 Hormone therapy 
Hormone therapy consists of slowing or destroying the cancer cells that use hormones to 
proliferate like breast and prostate cancers [8]. To do so, blocking the hormone production 
or interfering with the behavior of those hormones in the human body are the focus on 
this technique. Hormone therapy is often combined with other therapy as a preliminary 
treatment to reduce the tumor size or lower the risk that cancer will come back after 
treatment. 
 Stem cell transplants 
After chemotherapy or radiation therapy, blood stem cells have been destroyed to remove 
tumors and blood stem cells transplants focuses on their regeneration. Blood-forming 
stem cells induce the formation of different types of cells essential for the immune system, 
oxygen formation and blood clot [12]. This technique generally does not work directly 
on tumors but as recovery therapy. In case of allogenic transplants (receiving cells from 
a donor) a graft-versus-tumor effect can happen when high-dose treatments with white-
blood cells from the donor can target the remaining cancer cells in the patient’s body. For 
example, it has been studied in certain types of leukemia. 
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 Precision medicine 
Based on a genetic understanding of the disease, treatments can be selected by doctors 
[13].  A year-long study established that treating people with the same type and stage of 
cancer with the same treatment is inefficient on certain patients. This demonstrated that 
patient’s tumor grew depending on genetic changes. Potential drugs used in precision 
medicine are still in clinical trials since researchers have not yet discovered all the genetic 
changes or mutations that can induce cancer in the human body. The discovery of those 
mutations will then help on finding appropriate drugs that can target a specific mutation 
and finally be able to test the drugs in clinical trials. In addition, a phenomenon of drug 
resistance has been observed during the few stages of research, limiting the study of 
precision medicine [8]. 
 Summary of existing therapies 
It is common that a cancer treatment combines different therapies to cure cancer and 
minimize side effects. They have been showing promising results, but those techniques 
do not only target cancer cells, they also destroy the healthy cells, which possess the same 
capacity of fast division inducing a numerous side effects. Anemia, loss of appetite, 
fatigue, hair loss and nausea are some of them. Finding new treatment to avoid or 
minimize those side effects is one of the focus of some research. 
 
 Tumor construct 
Models are created to provide mechanistic insight into tumor growth/proliferation, 
migration, invasion, matrix remodeling, dormancy, extravasation, angiogenesis and drug 
delivery. A focus on 3D vascularization system for in vitro testing of therapeutic drugs 
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or for studying the behavior of the cancer cells of patients converges with the approaches 
used in tissue bioengineering. Even though the use of conventional 2D constructs have 
been well established, phenotypic differences between 2D cultures and cells residing in 
the original tumor location create the need to explore new ways to culture cancer cells in 
vitro with 3D systems being the most promising one [14]. During the initial synthesis, 
new drugs are generally first tested in 2D before moving into an in vivo model. However, 
cells behave differently in a 3D environment by expressing different surface receptors, 
proliferation rates and metabolic functions. Clinically speaking, the creation of in vitro 
models that can closely align with in vivo conditions is still needed as the ability to grow 
large tumors that contain functional vasculature. Researchers are still looking for an 
efficient way to prevent, detect and treat cancer. As mentioned previously, drug testing is 
a vital part of new cancer drug therapy development. Poor cell proliferation and 
distribution have been observed over the study of in vitro models.   
 Multicellular Tumor Structures 
The use of multicellular cancer spheroids have been widely used over the years in 
research [15][16]. Those spheroids are interesting as everyone represents a section of 
tissue that must be penetrated during drug delivery. Multicellular sheet constructs 
composed of stacks of cell monolayers on top of a vascular network is another method 
used in vascularization tumor models, which has also been successful used in cancer 
research [17]. Those spheroids can be created in suspension bioreactors or in 3D matrices 
to represent both cell-cell and cell-matrix interactions in vivo. Size is one of the limitation 
of those constructs (400-600 µm) but also other limitations include a limited oxygen input 
and nutrients availability for a successful mimic of a natural environment in situ.  
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When rotated slowly (50 rpm), cancer cell lines form naturally multicellular spheroids in 
a humidified environment.  
Multicellular Construct Tumors (MCTs) have been essentially used in the test of 
chemotherapeutic agents, and more precisely in novel drug delivery systems, in order to 
create a mapping response to a treatment. Promising results in the treatment of breast 
cancer have been shown using MCTs from a MCF7 breast cancer cell line using positron 
emission tomography tracers [18][19]. One of the most effective drug delivery systems 
studied has been the encapsulation of the cancer chemotherapeutic Doxorubicin in a 
polymeric micelle [20].  
Bioreactors have been well established in the study of cancer cell interactions, especially 
with stromal cells [21][22]. A bioreactor-based on a co-culture system has been 
developed to study the early stages of metastatic colonization [23]. Osteoblastic tissue 
(OT), by itself, and OT have been co-cultured with metastatic breast cancer cells in a 
compartmented bioreactor. Different stages of interaction and development have been 
observed in this clinical trial such as cancer cell adhesion, penetration and colony 
formation demonstrating high similarity to an osteoblast development and metastasis 
cancer colonization. 
 Engineered Scaffold 
Engineering scaffolds for the in vitro study of cancer cell growth in metastasis requires 
the maintenance of most critical interactions occurring in vivo. According to Lee et al. 
(2007) [24], the replication of the in vivo cell-cell and cell-ECM interactions are possible 
via the culture of cancer cells with specific ECM constituents. The epithelium and 
endothelium are lined and supported by a thin layer of specific ECM components called 
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the base membrane. This base membrane also contains proteins responsible for the cell-
matrix interactions regulating migration, attachment, repair and spread of cells in 
tumorigenesis such as laminin, collagen IV and entactin. Matrigel, a commercial 
available hydrogel made of the deposited basement membrane proteins of a Engelbreth-
Holm-Swarm (EHS) tumor cell culture has been used for both cancerous and non-
cancerous human prostate epithelial cell line cultures [25]. Cell-matrix interactions are 
favored via the Matrigel constituent, which also promotes cell proliferation and 
differentiation.  
The composition of the Matrigel does not reflect the native in vivo tumor completely since 
this matrix is not composed with the same elements. Some of the native proteins essential 
for the cell behavior such as collagen type I or hyaluronan are essential components for 
the proliferation of the ECM’s tumors and can affect the structure of the construct, if 
missing. Shekhar et al. (2001) [26] studied the co-cultured of breast preneoplastic 
epithelial cells with tumor-associated fibroblasts since they constitute a major component 
for tumor invasiveness by degrading the basement membrane. Other alternative 
approaches have been explored to mimic the native in vivo tumor microenvironment such 
as fibroblast-derived 3D matrix inducing desmoplastic characteristics, one of the markers 
responsible for ECM secretion [27]. The disadvantage of this matrix concerns the poor 
growth efficiency, especially with the breast cancer cell line MCF-10A [28]. The 
fibroblast-derived 3D matrix is a great model for cell-matrix interactions but does not 
fully demonstrate the composition and structure of the tumor microenvironment.  
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 3D-tissue engineered scaffold 
The goal of 3D-tissue engineered research is to provide a temporary structure to support 
a cell culture that can eventually be incorporated into the tissue. In order to investigate 
cell proliferation, growth and migration scaffold properties have been studied in order to 
mimic a tumor environment to replicate the native geometry unlike 2D cell monolayers 
(Fig. 2). Two main scaffolds belong to this category: natural and synthetic scaffolds. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: A schematic diagram [29]. 
(a) 2D cell culture on plastic (b) 3D cell culture in a porous scaffold; (c) in vivo tumor 
growth with supporting stromal cells. 
1.3.3.1 Natural Scaffold 
The main natural scaffolds used today are hydrogels composed of a natural polymer that 
has the capacity to swell and incorporate many times its weight with water. Hydrogels 
can be made of proteins such as collagen type I, laminin or hyaluronic acid. Hydrogels 
possess many advantages: give the cells the ability to remodel the hydrogel, increase the 
matrix density, align the cells [30]. Rapidly the construct of an in vitro organotypic breast 
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cancer model has been built from hydrogels using three different cell types [31]. Holliday 
et al. demonstrated the co-existence of different cell types resulting in a cellular network 
that mimicked the tumor and the pivotal role of tumor stroma fibroblasts in cancer 
progression. However, the network gives the cells a solid support to proliferate but it is 
still at a very low density to support adequately the residing cells. Recent technologies 
developed biomimetic scaffolds which increase the cell and collagen density [32]. Cell 
growth and morphology can be affected by the stiffness of collagen in the scaffold as 
demonstrated with the human tumorigenic mammary cell line (HMT352 MECs) culture 
[33]. This matrix stiffness potentially increased the malignant cell growth through the 
modulation of integrin adhesions. 
Another example of natural scaffolds is hydrogels composed with hyaluronic acid which 
is naturally present in the ECM and help in malignant tumor proliferation [34]. Mandal 
and Kundu [35] used a silk protein coming from a silkworm because they have great 
tensile and elasticity properties but also mechanical strength. Human breast cancer cells 
showed promising results with the integrin binding motif created. 
1.3.3.2 Synthetic Scaffold 
Most of the synthetic scaffolds are made from polymer such as polylactide (PLA), 
polyglocolide (PGA) and co-polymers constituted from both of those. Those components 
are biodegradable and can be shape differently: mesh, fibers, sponge which is an asset 
when looking to mimic a biomolecular structure [24]. Even if poor cell adhesion has been 
observed, this network is mechanically stronger than natural scaffold which encourages 
researchers to explore surface modification approaches to improve the cell attachment 
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[36]. Bulk modification approaches have been also tested as a means for synthetic 
polymer functionalization [37]. 
The functionalization of a polyethylene glycol (PEG) with peptides such as RGD have 
been demonstrated increasing cell-cell and cell-ECM interactions [38]. An example of 
this successfully designed has been done by Loessner et al. [39] when ovarian cancer cells 
have been encapsulated in a PEG-based hydrogel scaffold. A structure similar to an in 
vivo mass composed with small compact spheroids has been obtained.  
A biodegradable scaffold can be created by using and modifying a combination of porous 
PLGA/PLA micro-particles. Those particles possess a large surface area to encourage cell 
attachment and proliferation. Sahoo et al. [40] incorporate various materials in the 
particles previously mentioned and showed that the human breast cancer cells MCF-7 
adhere to the PLA particles when incorporated with vinyl alcohol (PVA). 
 
 Research motivations 
Breast and prostate cancer are currently two of the most studied cancers in research. As 
previously described, the use of 3D engineered scaffolds has shown promising results. 
The Human Umbilical Cord has been chosen as a scaffold for a new 3D tumor construct 
system in this study. 
 Breast Cancer 
Approximately one every eight women diagnosed with cancer. It can take from five to 30 
years to develop and it has been shown that it excessed 10-15 years to follow the 
development of breast carcinoma in situ and its progression.  
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 Prostate Cancer 
Compared to breast cancer, one in every seven men is diagnosed with prostate cancer and 
one man in 39 will die [8]. Cancer begins when the cells present in the prostate gland start 
to grow uncontrollably. Most of the prostate cancers are called adenocarcinomas because 
they are formed with the gland cells.  
 The Matrix: Human Umbilical Cord  
A HUC is a conduit that delivers oxygen and nutrient-rich blood from the placenta to the 
fetus via its vein and reject deoxygenated, nutrient-depleted blood via its two arteries 
(Fig. 3). The human umbilical vein endothelial cells (HUVECs) have been used as a 
vascular model system since 1973 and still in use today [41]. The HUC’s ECM is in the 
Wharton’s jelly and is rich in collagen and largely 
made of mucopolysaccharides (hyaluronic acid and 
chondroitin sulfate). Fibroblasts and macrophages 
are also present in this gelatinous substance [42]. 
Hyaluronic acid promotes cell adhesion and 
migration and might be involved in malignant 
tumor progression [43] (Fig.4). The synthetization 
of HA plays a role at all stages of cancer 
metastasis.  
 
Figure 3: Representation of a 
HUC [24]. 
A Human Umbilical Cord is 
composed of two arteries, one 
vein covered by Wharton’s 
jelly. 
 
13 
 
Figure 4: The process of cancer metastasis in which HA-associated molecules play 
a role in the steps. 
Abbreviations: hyaluronic acid (HA), hyaluronic acid synthase (HAS), hyaluronic acid 
receptor (HAR), hyaluronidase (HAase/HYAL) by Lgurski - Own work, Public Domain, 
https://commons.wikimedia.org/w/index.php?curid=6881835). 
 
 Research objectives 
 Hypothesis 
Due to the HUC properties presented above, the HUC is a potential scaffold for 
generation of tumor constructs. The vein isolated from of a HUC may be used as a 
vascular system. The drug delivery would be done from the vein and through the 
Wharton’s Jelly where cancer cell would be seeded beforehand. This paper is focused on 
the first part of the 3D model that involves the study of the potential adhesion of cancer 
cells on the Wharton’ Jelly as described in the following objectives. 
 Objective 1 
It has been hypothesized that cancer cells can adhere and develop on the ECM of the 
decellularized Wharton’s jelly of a HUC on Wharton’s jelly or luminal side. This 
objective has been conducted via new established methods (as outlined in Materials and 
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Methods, Seeding and culturing on decellularized construct, Section 2.2). 
Additionally, two baseline constructs are produced as controls: a non-seeded 
decellularized HUC and a cancer cell culture conducted in a 6-well plate that act as a 
positive control with regards to adhesion and growth. 
 Objective 2 
It has been hypothesized that cancer cells can adhere better to a non-decellularized HUC’s 
Wharton’s jelly with the assistance of the existing Wharton’s Jelly stem cells to 
eventually create a microenvironment that contain cancer and mesenchymal cells in order 
to study mesenchymal cancer cells interactions and the growth of cancer cells in the 
presence of mesenchymal cells. This objective has been conducted via new established 
methods (as outlined in Materials and Methods, Seeding and culturing on non-
decellularized construct, Section 2.3). Additionally, two baseline constructs are to be 
produced as controls: a non-seeded fresh Wharton’s Jelly construct and a cancer cell 
culture conducted in a 6-well plate that act as a positive control with regards to adhesion 
and growth. 
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2. Materials and methods 
 Cancer cells used in this thesis 
  Cell line  
Two types of human adenocarcinoma cell lines derived from the metastatic site of the 
tumor have been utilized: MDA-MB-231 (ATCC® CRM-HTB-26™) and PC3 (ATCC® 
CRL-1435™).  The MDA cells originate from a female human mammary gland breast 
tissue and the PC3s come from a male human prostate tissue. Following the ATCC® 
directions, the cells are stored in liquid nitrogen until needed. Cells were thawed at room 
temperature and gently mixed separately with their respective L-15 and F-12K media 
(described in section §2.1.2) before being split into two T-75 cell culture flasks (Corning; 
Ref. # 430641U), which were then brought to a total volume of 13mL with fresh media. 
The following day, the flasks were rinsed with 3 to 5mL of Dulbecco’s Phosphate 
Buffered Saline (PBS; Gibco; Ref. # 21600-010) and 13mL of fresh media was added to 
each flask. This step removed any non-adherent cells such as hematopoietic stem cells 
and erythrocytes. 
 Media 
In order to follow the culture conditions established by the ATCC®, two types of cell 
media were used: L-15 medium for the breast cancer cell line and F-12K medium for the 
prostate cancer cell line. The L-15 medium was prepared from Leibovitz's L-15 Medium 
powder (Gibco; Lot. #1665614) and the F-12K medium was prepared from the nutrient 
mixture F-12 ham powder (Sigma Aldrich; Lot. #SLBG0236V) with 1.18g of sodium 
bicarbonate (Sigma Aldrich; Cat. #S5761). 
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For both sets of media the pH of the reconstituted powder was adjusted to 7.2-7.4 and 
filter-sterilized with a 0.22µm bottle-top vacuum filter (Sigma Aldrich; Cat. 
#CLS430769). 10% vol/vol fetal bovine serum (FBS; Atlanta Biologics; Cat. # S11150) 
and 1% vol/vol antibiotic-antimitotic (Gemini Bio-Products; Cat. #400-101) were added 
to the solution. 
At the beginning of each experiment, new media was prepared and automatically replaced 
after one month of storage at 4°C or reaching a pH outside of the range of 7.2-7.4. 
 Cell culture and expansion 
The MDA cells (MDAs) were kept in an incubator at 37°C supplemented with 0% CO# 
and the PC3 cells (PC3s) were kept in an incubator at 37°C supplemented with 5% CO#.  
Their respective medium (L-15 for MDAs and F-12K for PC3s) were changed every two 
days. Cells were passaged once the T-75 flasks reached 70-80% confluency (Fig.5).  
The cells were lifted from their T-75 cell culture flask by first vacuuming the media and 
rinsing each flask with 4mL of PBS. 3 mL of Trypsin-EDTA (Sigma; Ref. # T4049) was 
added to each flask and placed in the incubator for 5 min before placing the cells with 
excess media in a falcon tube. This tube was then centrifuged at 1100 rcf for five minutes 
to create a cell pellet. The media and the trypsin contained in the supernatant were 
removed, and the cell pellet resuspended into fresh media.  Each new sterile T-75 flasks 
was given fresh media for a total volume of 13mL resulting in a cell concentration of 
375,000 to 1 million. 
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Figure 5: Microscope Images PC3 CRL-1435 [44]. 
Top views of PC3 culture in T-75 cell culture flask. Scale bar is 100 µm. a – Low density 
of culture (30%) b – High density of culture (90%). 
 
 MDAs and PC3s cultured in a 6-well plate 
In order to compare the cell attachment across experiments conducted in this paper, it has 
been necessary to culture the MDAs and PC3s in a 6-well cell culture treated plate 
(Costar, Lot. # 3391601). Cells were lifted from their T-75 culture flasks as described in 
section §2.1.3 and resuspended to have a cell concentration of about 50,000 cells into 
each well for a total volume of 5mL, complete with fresh media. As for the cell culture 
expansion, the media was changed every two days.  
The determination of cellularity (via dsDNA quantification) was assessed. The cells were 
lifted from the bottom of the well by first vacuuming the media and rinsing each well 
with 2mL of PBS. 1mL of Trypsin-EDTA was added into each well, and the plate was 
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placed in the incubator for five minutes before placing the cells with excess media in a 
falcon tube. This tube was then centrifuged at 1100 rcf for five minutes to pelletize the 
cells. The media and the trypsin contained in the supernatant were then removed to 
resuspend the pellet of cells in fresh media to have a final volume of 1mL. This volume 
can be store in the freezer at -20°C and prepared for the assay, when needed.  
Samples were collected after six hours, two days, six days of culture. After six days of 
culture, the cells were more than 90% confluent and no further samples were taken. It has 
been assumed that the cellularity inside the 6-well plate would remain constant after six 
days of this experiment due to the seeding concentration chosen (about 50,00 cells/well). 
 
 Seeding and culturing on decellularized construct 
 Scaffold preparation 
Human Umbilical Cords (HUC) were collected from Norman Regional Hospital 
(Norman, OK) with the approval of the local Institutional Review Board. Using personal 
proper equipment (PPE) the cords were rinsed with distilled water and cut to 7.5 cm in 
length.  
The HUC were then mounted on a steel mandrel and frozen at -80°C overnight and kept 
for up to two weeks. A computerized lathe was used to isolate the Human Umbilical Vein 
(HUV) from the frozen tissue mounted on the steel mandrel. The lathe removes the 
extraneous Wharton’s jelly, leaving a tissue thickness of 0.75 mm for a diameter of 6.75 
± 0.25mm designed for this experiment (this parameter is adjustable). Prior to 
decellularization, the HUVs were cut to an approximate size of 2.0 to 2.5 cm length 
(Fig.6) to fit in the 6-well plate. 
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Figure 6:  2.0 to 2.5 cm piece of HUV prior to decellularization. 
The decellularization process consists of different washes on a shaker. To make the 
washes simpler to the operator, a stain steel sink strainer is placed on top of a 1L baker to 
drain the HUVs (Fig.7).  
 
 
 
 
 
 
  
Figure 7: Draining the HUVs. 
The first wash is made in 1% Sodium Dodecyl Sulfate (SDS; JT Baker, CAS 151-21-3) 
for 24 hours. Then the HUVs are washed in 70% ethanol for another 24 hours to remove 
any SDS residue on the interior of the veins. The next step consists of 10, 20 and 30 
minute washes of DI water, then two hours of 0.2% per-acetic-acid (Sigma Aldrich, St. 
Louis, MO) which leads to the sterilization of the HUVs. The following washes must be 
processed under sterility. Another 10, 20, 30 minute and 24 hours washes in DI water are 
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processed to remove any acid residue before a last 24-hour wash in a phosphate buffer 
(Appendix B) of 7.2-7.4 pH. The pH is controlled to be between 7.2-7.4 or the HUVs are 
washed for another 24 hours in new phosphate buffer before being stored for no longer 
than a week at 4°C before cell seeding. 
In a sterile environment, the scaffolds were cut open, flattened and placed in a 6-well 
tissue-culture plate (non-cell culture-treated) with the Wharton’s jelly facing up and the 
vein side facing down. This scaffold is called HUV for the rest of the experiment.  
 Seeding 
2.2.2.1 Preliminary experiment 
MDAs were lifted from their T-45 cell culture flask as described in section 2.1.3. and 
200µL were pipetted from a cell suspension containing the desired concentration of cells 
(about 50,000 cells/200µL) dispersed in the appropriate media and placed on the top of 
the scaffold with care to conserve the surface tension. The plates were then placed in the 
incubator at 37°C and 0% of CO2 for two and a half hours, and 5mL of the appropriate 
media was added into each well. As for the cell culture expansion, the media was changed 
every two days. 
After this first test experiment, with MDAs only, the scaffolds were observed floating 
with no significant cell attachment or presence. It has been hypothesized that those results 
could be due to the significant movement of the scaffolds inside the well. To fix this issue, 
a 3D printed part was inserted into the system to maintain the scaffold on the bottom of 
the well. More detail about this piece, called the Pizzabox, is described in section §2.4. 
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2.2.2.2 Final experiment 
First, the HUV scaffolds were placed in a 6-well tissue culture plate (non-cell culture-
treated) with the Pizzabox on top of it. Both MDAs and PC3s were lifted as previously 
described in section §2.2.2.1 and dispersed in the appropriate media at the desired 
concentration of approximately 50,000 cells/200µL. The Wharton’s jelly side of the HUV 
scaffolds were seeded with PC3s and MDAs separately with the help of the inside ring of 
the 3D printed part and care was taken to conserve the surface tension. Those samples are 
called seeded HUV. 
Control samples have been established by placing the HUV scaffold at the bottom of the 
well toped with the Pizzabox. 200µL of the appropriate media has been deposited on the 
Wharton’s jelly of the HUV scaffold with the help of the inside ring of the 3D printed 
part and care was taken to conserve the surface tension. Those samples are called 
decellularized HUV. 
The seeded and decellularized HUV scaffolds were then placed for two and a half hours 
at 37°C in an incubator supplemented with 0% CO2 for the scaffold seeded with MDA 
and in the incubator supplemented with 5% CO2 for the scaffold seeded with PC3 in order 
to help the cancer cells attach to the scaffold. Each well was then filled with 5mL of the 
appropriate media: L-15 for MDA and F-12K for PC3 with care and by the side of the 
well. As for the cell culture expansion, the media was changed every two days. 
 Species measurement methods 
Various means have been investigated in this experiment. Two types of samples were 
used for determination of the cellularity (via dsDNA quantification) and examination of 
the tissue structure (via histology with Hematoxylin and Eosin staining). First, media was 
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discarded and the samples were separated from their Pizzabox. Second, the samples were 
cut in a circle of 1.3 cm diameter corresponding to the size of the inside ring circle of the 
Pizzabox where cells were seeded to maintain the size sample’s homogeneity. For 
cellularity, the samples were placed in 500µL up to 1mL of nanopure water prior to be 
stored in the freezer at -20°C before being prepared for the assay. For the examination of 
the tissue structure, the samples were fixed in 10% formalin overnight before being 
washed in 70% ethanol and stored in the refrigerator at 4°C in 70% ethanol up to several 
weeks. 
Samples were collected after six hours, two days, six days of culture for the first 
experiment and an additional sample was collected after 10 days of culture for the second 
experiment. Every time, three to five samples were collected to process a dsDNA 
quantification and two samples were collected for histology from decellularized and 
seeded HUV. 
 
 Verification of the decellularization process 
 Fresh cords 
HUCs were collected from Norman Regional Hospital (Norman, OK) with the approval 
of the local Institutional Review Board. Using personal proper equipment, the cords were 
washed with warm water and Wharton’s jelly pieces were extracted and placed for a few 
days (until their weight remained constant) in a vacuum chamber. Dry pieces were then 
weighed and placed in 1mL of nanopure water prior to be stored in the freezer at -20°C. 
Piece weights varied from 0.0229 to 0.0467g. 
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 Decellularized cords 
The decellularized samples were processed as described in the section §2.2.1 and placed 
for a few days (until their weight remain constant) in a vacuum chamber. Dry pieces were 
then weighed and placed in 1mL of nanopure water prior to being stored in the freezer at  
-20°C. Pieces weighed from 0.0455 to 0.0929g. 
 Species measurement methods 
Various means have been investigated in this experiment. Two types of samples were 
sacrificed to determine the cellularity (via dsDNA quantification) and examination of the 
tissue structure (via histology with Hematoxylin and Eosin staining). For the examination 
of the tissue structure, the samples were fixed in 10% formalin within 24h hours before 
being washed in 70% ethanol and stored in the fridge at 4°C in 70% ethanol up to several 
weeks. Five samples of fresh and five samples of decellularized cords were collected to 
process a dsDNA quantification and two samples of fresh and two samples of 
decellularized cords were collected for histology. After each step of the decellularization 
process three samples were collected to process a dsDNA quantification step by step. 
 
 Verification of the non-effect of the Pizzabox on cellularity 
 Pizzabox characteristic 
The “Pizzabox,” created by Patrick McKernan (Fig. 8-a) and improved by Chelsea Coffey 
(Fig. 8-b) to have stronger spikes and a faster 3D printing time is presented in Fig. 8. 
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Figure 8: 3D printed scaffold holder “The Pizzabox”. 
a - Patrick McKernan piece, b - Chelsea Coffey modified piece used in this experiment 
 
Double rings have been created, an inside “seeding ring” which helps maintain surface 
tension during the seeding process and an outside ring leaving a gap to facilitate the media 
change without touching and potentially damaging or contaminating the construct. The 
weight of a flat double ringed construction has been observed to not be heavy enough to 
hold down the scaffold at the bottom of the wells. “Legs” were then added to this 
construct, giving it its name, due to its similarity 
with a Pizzabox holder. Those legs are necessary 
to hold down the scaffold with the weight of the 6-
well plate’s lid. 
Two different 3D printing materials were used to 
3D print the Pizzabox in this research (Fig.9). The 
white wire (Makerbot PLA MP05780) has been 
used for the six-day experiment of both MDA and 
PC3 seeded constructs and the blue one (Makerbot 
PLA MP005776) for the 10-day experiment of 
ba 
 
 
 
 
 
 
 
 
Figure 9: Pictures of  
the Blue and White Pizzabox. 
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both MDA and PC3 seeded construct. Both have been tested to see if they influenced the 
cellularity of the experiment.  
 Seeding 
The Pizzabox was placed inside the well of the 6-well cell culture-treated plate. The cells 
were lifted from their T-45 cell culture flask as described in the section §1.5.3. and 200µL 
were pipetted from a cell suspension containing the desired concentration of cells (about 
50,000 cells/200µL) dispersed in the appropriate media and placed at the bottom of the 
well through the inside ring of the Pizzabox with care to conserve the surface tension. 
Those samples have been called Blue and White Pizzabox for the cells respectively 
cultured with the blue and white Pizzabox. 
Control samples have been established as described in the section §2.1.4 consisting of a 
regular cell culture in a 6-well culture seeded plate. 
The plates were then placed in the incubator at 37°C with 0% of CO2 for the MDA culture 
and with 5% of CO2 at two and a half hours and 5mL of the appropriate media was added 
into each well. As for the cell culture expansion, the media was changed every two days. 
 Species measurement methods 
Only the determination of cellularity (via dsDNA quantification) was assessed. The 
Pizzabox was removed from the well and discarded. The cells were then lifted with the 
same method described in section §2.1.4 and stored in the freezer at -20°C before being 
prepared for the assay.  
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 Seeding and culturing on non-decellularized construct 
 Scaffold preparation 
HUCs were collected from Norman Regional Hospital (Norman, OK) with the approval 
of the local Institutional Review Board. Using personal proper equipment, the cords 
where washed with warm water and Wharton’s jelly pieces were extracted and weighed. 
Piece weights varied from 0.0244 to 0.0708g. 
In order to amplify the number of Wharton’s jelly cells already present on the cord, the 
pieces were placed in a 24-well plate for tissue culture in a growth media and cultured for 
48 hours. Those scaffolds are named cultured-scaffolds. 
 Seeding 
After transferring the scaffold previously cultured for 48 hours into a new well, MDAs 
and PC3s were lifted from their T-45 cell culture flask as described in the section §2.1.3. 
and re-suspended in their appropriate media. Different volumes were pipetted to have a 
seeding concentration of 72,602.67 MDA cells / g of tissue and 110,324.34 PC3 cells / g 
of tissue and were placed on the top of the cultured-scaffold with care, to conserve the 
surface tension. Those concentrations correspond to the one already measured on the 
cultured-scaffolds.  
Control samples have been established by adding the requisite volume of media to 
maintain the surface tension on top of the cultured-scaffold. 
The plates were then placed in the incubator at 37°C with 0% of CO2 for the MDA culture 
and with 5% of CO2 at two and a half hours and 5mL of the appropriate media was added 
into each well. As for the cell culture expansion, the media was changed every two days. 
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 Samples 
Only the determination of cellularity (via dsDNA quantification) was assessed. First, 
samples were taken after the Wharton’s jelly cells expansion culture on the cultured-
scaffolds and then after six hours, two days and six days of cancer cells seeding on top of 
the Wharton’s jelly cells. 
 
 Cellularity via dsDNA Quantification 
 Tissue samples preparation 
Measurements of double-stranded DNA (dsDNA) were made in the solution of constructs 
immersed in nanopure water and subjected to sonicate for five seconds. Then 200µL of 
Trypsin was added to the solution before being vortexed for five seconds and incubated 
at 37°C for one hour. Constructs were finally sonicated for 10 seconds before applying 
three freeze-thaw cycles, wherein the constructs were sequentially frozen solid at -20 °C, 
thawed at room temperature and vortexed for five seconds prior to re-freezing.  
 Cell samples preparation 
Measurements of double-stranded DNA (dsDNA) were made in the solution of cells 
immersed in 1 mL of the appropriate media and subjected to three freeze-thaw cycles 
wherein the constructs were sequentially frozen solid at -20 °C, thawed at 25 °C and 
vortexed for 5 seconds prior to re-freezing.  
 DNA assay 
DsDNA content utilizing a Quant-iT™ PicoGreen® dsDNA assay kit (Invitrogen; Cat. 
#P11496) was measured on the previous resulting cell lysate. Five standards over the 
range of 0.1 to 3µg/mL were prepared from a 100µg/mL λ-DNA furnished in the kit. 
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257µL of a buffer solution (10 mM Tris-HCl, 1 mM EDTA, 1.3 µL PicoGreen® reagent, 
pH 7.5) were placed at the bottom of an opaque 96-well plate and topped with 43µL 
aliquots of all standards and samples. After incubation at room temperature for five 
minute, fluorescence at 480/520nm excitation/emission wavelengths was measured on a 
Synergy 50 HT Multi-Mode Microplate Reader. The standard curve was used to quantify 
the concentration of the samples from the intensity values measured to obtain the content 
of dsDNA per sample. Triplicate of standards and samples were run to ensure the 
replicability of the experience. 
To convert the intensity measured to a quantity of dsDNA in sample in 𝜇𝑔, the following 
calculations were applied to each measure: Quantity	of	dsDNA	in	sample	 pg = 	C	(µg/mL)	×	VBCDEFG	HIJKLF(mL) 
 
For some of the experiments, a cell quantity was necessary to obtain and was calculated 
as followed: Quantity	of	dsDNA	in	sample	 pg = 	C	(µg/mL)	×	VBCDEFG	HIJKLF(mL)×10O 
 Quantity	of	cells = QuantityQHRST	UG	HIJKLF	(pg)QuantityQH	RST	UG	DGF	VFLL	(pg/cell) 
 
The quantity of dsDNA in one cell is known from performing the same assay on known 
quantities of cells culture in a T-75 flasks previously counted with a hemocytometer. For 
this experiment, the quantity of dsDNA in one MDA cell is equivalent to 7.05pg and the 
quantity of dsDNA in one PC3 cell is equivalent to 6.75pg. 
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 Histology 
Samples were removed from the storage solution and cut into 0.5 cm section. They were 
then placed in increasing concentrations of ethanol to be dehydrated and in Clear Rite 3 
(Thermo Scientific, ref#6901) to be finally embedded in paraffin for tissue embedding 
(Sigma, #145686-99-3) More details of this protocol can be found in Appendix C: 
Paraffin embedment protocol. 7µm thick slices of tissue embedded in paraffin were sliced 
using a microtome and were mounted on Selectfrost Microscope Slides (Fisher Scientific, 
cat#12-550-003). Gill-1 Hematoxylin (Thermo Scientific, ref. 72411) and Eosin-Y 
(Thermo Scientific, ref. 71311) were used to stain the slides to observe ECM quality and 
possibly to visualize the number of cells present on the scaffold. More details can be 
found in Appendix D: Hematoxylin and Eosin staining protocol. An optical microscope 
(Nikon Eclipse E800), ImageJ software and the FibrilTool plug-in were used to analyze 
lateral sections of the construct. It has been checked that the microscope’s settings 
remained unchanged for the recording of each histology image. 
The porosity was also roughly measured with ImageJ and the analyzer of particles via: 
 Porosity = Sum	of	particles	area	measuredTotal	sample	area  
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3. Results and Discussion 
 6-well culture 
Figure 10 represents the cellularity of both the PC3s and MDAs cultured in a 6-well 
culture coated plate. For both the MDAs and PC3s the cells proliferate exponentially. It 
has been observed under the microscope that both cell lines reach the maximum 
occupancy of the 6-well plate and after six days the number of cells present remain 
constant and stop increasing due to a lack of space. From about 50,000 cells seeded 
originally, there are about 450,000 PC3s and about 260,000 MDAs cultured after six days. 
 
Figure 10: Cellularity of the PC3s and MDAs cultured in 6-well culture coated plate. 
Dashed line indicates initial seeding density of about 50,000 cells/well. 
 
For the purpose of this study, it has been necessary to calculate the amount of DNA 
present in those cultures with: 
QuantityQHRST	UG	DGF	VFLL	(µg) = Quantity	of	cells	×	QuantityQHRST	UG	HIJKLF	(pg/cell)10O  
Figure 11 represents the conversion in µg of DNA of the PC3s and MDAs cultured with 
the same observations done with Figure 10 over 6 days. 
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Figure 11: Amount of DNA representing the PC3s and MDAs cultured in 6-well 
culture coated plate. 
Dashed line indicates initial seeding density of about 0.38µg of DNA. 
 
 Seeding and culturing on decellularized construct 
 DNA Assay 
Cellularity has been studied for the MDA-seeded HUV and for the PC3-seeded HUV 
over a period of six to 10 days to observe the cell evolution on the different constructs. 
The p-values have been established according to a one-way ANOVA with post-hoc 
Tukey HSD test. 
3.2.1.1 MDA 
Figure 12 shows the amount of DNA present with the decellularized HUV seeded with 
MDA construct for a duration of six days. Compared to the 6-well culture, the seeded 
HUV is statistically different as well as the decellularized HUV after six hours and six 
days of culture. After two days of culture, the content in DNA decreases for the seeded 
and decellularized HUV and drops significantly to almost zero. There is no statistical 
difference between the seeded and decellularized HUV at any time of the experiment. 
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Figure 12: Construct HUV seeded with MDA Day 1 – 6. 
DNA content of HUV seeded with MDA as a function of the duration has been presented 
in this figure for a period of six days. * indicates p-value<0.05 ** indicates p-value < 0.01 
compared to the cells cultured in the 6well culture plate. Data represented as mean ± 
standard deviation. A sample size of n = 3 was used. Dashed line indicates initial seeding 
density of about 50,000 cells/construct or about 0.36µg of DNA. 
Figure 13 represents the evolution of the quantity of DNA per construct during a 10-days 
experiment. Compared to the culture in the 6-well plate, the seeded and decellularized 
HUV are statistically different at all times. The amount of seeded and decellularized HUV 
remain non-statistically different during the whole experiment. There is an increasing 
amount of DNA after two days of experiments to finally decrease over time and reach 0.1 
µg of DNA after 10 days of culture.  
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Figure 13: Construct HUV seeded with MDA Day 1 – 10. 
DNA content of HUV seeded with MDA as a function of the duration has been presented 
in this figure for a period of 10 days. ** indicates p-value<0.01 compared to the cells 
cultured in the 6well culture plate. Data represented as mean ± standard deviation. A 
sample size of n = 5 was used. Dashed line indicates initial seeding density of 50,000 
cells/construct or about 0.35µg of DNA. 
Looking at the samples measured in two different experiments (Figure 12 and Figure 13) 
the DNA content for day 2 is around 0.3 µg of DNA in the first experiment and 1.1 µg of 
DNA for the second experiment concerning the seeded construct. A similar difference is 
noticed for the six days’ sample.  
3.2.1.2 PC3 
Figure 14 shows the amount of DNA present with the decellularized HUV seeded with 
PC3 construct for a duration of six days. Compared to the 6-well culture, the seeded HUV 
is statistically different as well as the decellularized HUV after six hours and six days of 
culture. After two days of culture, the content in DNA increased for the seeded and 
decellularized HUV and dropped to almost zero at the end of the experiment. There is no 
statistical difference between the seeded and decellularized HUV at any time of the 
experiment. 
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Figure 14: Construct HUV seeded with PC3 Day 1 – 6. 
DNA content of HUV seeded with PC3 as a function of the duration has been presented 
in this figure for a period of 6 days.  ** indicates p-value <0.01 compared to the cells 
cultured in the 6well culture plate.  Data represented as mean ± standard deviation. A 
sample size of n = 3 was used. Dashed line indicates initial seeding density of about 
50,000 cells/construct or about 0.34µg of DNA. 
Figure 15 represents the evolution of the quantity of PC3 per construct during a 10-days 
experiment. Compared to the culture in the 6-well plate, the seeded and decellularized 
HUV are statistically different at any time. The amount of seeded and decellularized HUV 
remain non-statistically different during the whole experiment except after 10 days of 
culture even if the DNA content remains relatively close to zero.  
There is an increasing amount of DNA for the seeded HUV after two days of experiment 
to finally decrease over the time and reach 0.1 µg of DNA after six days of culture and 
remain constant after 10 days.  
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Figure 15: Construct HUV seeded with PC3 Day 1 – 10. 
DNA content of HUV seeded with PC3 as a function of the duration has been presented 
in this figure for a period of 10 days. * indicates p-value <0.05 ** indicates p-value <0.01 
compared to the cells cultured in the 6well culture plate or between the seeded and non-
seeded construct. Data represented as mean ± standard deviation. A sample size of n = 5 
was used. Dashed line indicates initial seeding density of about 60,000 cells/construct or 
about 0.42µg of DNA.  
Looking at the samples measured in two different experiments (Figure 14 and Figure 15) 
there is one value around 0.3 µg of DNA and another one at 1.1 µg of DNA for seeded 
construct. The similar difference is noticed for the six days’ sample.  
To conclude, in both MDA and PC3 studies, the 10-days experiments have been 
conducted to confirm the previous observations but also go further in the eventual cellular 
development. It is clearly shown that there is no growth even on a longer time frame and 
that the reproducibility of the experiment is questionable. After the experiments 
conducted on the cell-tissue attachment with both MDA and PC3 cell lines, it is also 
hypothesized that the decellularized cords might have been contaminated prior to those 
experiments. Consequently, the decellularization process needs to be investigated further 
and those past experiments are unfortunately not conclusive.  
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3.2.1.3 Decellularization process 
A dsDNA assay has been processed on five different samples coming from different 
decellularization procedures and the average DNA amount in the fresh cords was 
measured at 9.43 ± 3.75µg DNA / g of dry tissue and decellularized cords at 12.24 ± 
5.32µg DNA / g of dry tissue, which is under the limit of 50µg DNA / g of dry tissue 
[45].  
Figure 16 shows the cellularity of three different constructs from three different 
decellularization processes after different decellularization steps. The fresh cord results 
are not significantly different from the ones listed above, as well as the decellularized 
HUV or cords stored in PBS DNA content values (p-values>>0.05).  
From fresh cord samples at 11.69 ± 1.49µg DNA / g of dry tissue the quantity of DNA 
has been reduced to 0.40 ± 0.03µg DNA / g of dry tissue after the last DI water wash 
before transferring the HUV to PBS where the DNA content detected was 15.43 ± 4.27µg 
DNA / g of dry tissue after two days of storage. This graph demonstrates that the 
decellularization process has successfully been conducted respecting the limit of 50µg 
DNA / g of dry tissue. 
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Figure 16: Comparison of the cellularity results after the different decellularization 
steps. 
Fresh stands for samples taking on a fresh cord, lathe after lathe procedure, SDS after the 
SDS wash, EtOH after the EtOH wash, Peracetic for after the peracetic wash, DI for after 
the DI washes and PBS for after few days stored in PBS and decellularized. ** indicates 
p-value<0.01 compared to the fresh HUV. Data represented as mean ± standard deviation. 
A sample size of n = 3 was used. The dashed line indicates the limit for demonstrating 
that the decellularization is satisfying regarding immune reactions and graft rejection 
risks (=50µg DNA/g of dry tissue).  
It is hypothesized that the PBS storage solution induces an increase of DNA quantity even 
if the measurements are still under the established limit. This might come from a bacterial 
or fungi contamination.  
It has been previously pointed out that the design of the experiment is questionable due 
to its non-repeatability. It is important to study the potential effect of the Pizzabox on the 
cellularity of a regular cell culture in a 6-well culture coated plate to confirm its use in 
further studies. 
3.2.1.4 Pizzabox 
Figure 17 represents the cellularity of MDAs cultured in different conditions. The dash 
lines represent the initial cell seeding of about 50,000 cells / well. All the MDA cultured 
with both Pizzabox types are statistically different to the MDAs cultured in a 6-well 
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culture coated plate. Cells are proliferating with the presence or absence of the Pizzabox 
at any time of culture. The MDAs cultured with the Pizzabox are growing slower than 
the MDAs by themselves after six days of culture, and there is a higher cellularity with 
the blue Pizzabox than the white one. 
 
 
Figure 17: Pizzabox seeded with MDA Cellularity Day 1 – 6. 
Cellularity of Pizzabox seeded with MDA only (no scaffold) as a function of the duration. 
Blue Pizzabox stands for MDAs cultured with the blue Pizzabox and White Pizzabox 
stands for MDAS cultured with the white Pizzabox. * indicates p-value <0.05 ** indicates 
p-value <0.01 compared to the cells cultured without Pizzabox. Data represented as mean 
± standard deviation. A sample size of n ≥ 3 was used. Dashed line indicates initial 
seeding density of about 50,000 cells / well.  
 
Figure 18 represents the cellularity of PC3s cultured in different conditions. The dashed 
line represents the initial cell seeding of 50,000 cells / well. All the PC3s cultured with 
any kind of Pizzabox have been shown statistically different to the PC3s cultured in a 6-
well culture coated plate except after three days of culture. Cells are proliferating with 
the presence or absence of the Pizzabox at any time of culture. The PC3s cultured with 
the Pizzabox are growing slower than the PC3s by themselves after six days of culture. 
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Figure 18: Pizzabox seeded with PC3 Cellularity Day 1 – 6. 
Cellularity of Pizzabox seeded with PC3 only (no scaffold) as a function of the duration. 
Blue Pizzabox stands for PC3s cultured with the blue Pizzabox and White Pizzabox 
stands for PC3s cultured with the white Pizzabox. ** indicates p-value<0.01 compared 
to the cells without Pizzabox at each time. Data represented as mean ± standard deviation. 
A sample size of n = 3 was used. Dashed line indicates initial seeding density of about 
50,000 cells / well or about 0.34µg of DNA. 
The results show that both the blue and white Pizzabox inhibit the cell proliferation 
compared to cultures without Pizzabox. The Pizzabox might be leaching toxic chemicals 
coming from the colored filament used to build it or mechanically damaging the cells. It 
is important to note that the Pizzabox was not completely stable in the 6-well plate as it 
was with the HUV and it is also possible that the piece might have slid inside the well 
even if care was taken to manipulate the plates. It has also been noticed that after six days 
of experiment for the cells only, the well was almost at 80% confluency and reached its 
maximum cellularity. 
3.2.1.5 Summary of cell-tissue attachment cellularity analysis 
Overall, the above graphs demonstrated a successful decellularization below the limit of 
50µg DNA / g of dry tissue. It has been hypothesized that even if the decellularization 
40 
process stay way below the established maximum limit, there is a remnant amount of 
DNA present on the HUVs after the storage in the PBS solution that based on the DNA 
content of the cords prior their storage it must come from a potential contamination.  
Studying the structure of the cords would show if cells have been removed during the 
decellularization process and if there is a modification in the properties of the matrix. 
 Histology 
Histology images have been treated via the software Image J and a porosity estimation 
has been made from three samples from three different constructs with the analysis 
particles tools. It is important to note that only the 10-day experiment is presented due to 
high similarities with the six’ days culture regarding the histology images and the porosity 
calculated.  
3.2.2.1 MDA experiment 
Table 1 represents the porosity of both control and HUV/MDA construct after 10 days of 
culture. The control porosity is relatively close to the HUV/MDA construct porosity 
except after two days and six days of culture where the control possess a smaller porosity. 
 
 6	HOURS	 2	DAYS	 6	DAYS	 10	DAYS	
CONTROL	 38.4%	± 11.1	 16.1%	± 1.9	 31.1%	± 6.17	 45.14%	± 5.95	
HUV/MDA	 45.1%	± 2.11	 33.1%	± 2.1	 60.5%	± 3.79	 41.2%	± 2.82	
 
Table 1: Porosity of control and HUV/MDA construct. 
 
Coupling those results to Figure 19, which shows the control and HUV/MDA construct 
histology images at x4 magnification, there is a higher fiber organized structure on the 
control after two days of experimenting (Fig.19-c) than in the HUV/MDA construct 
41 
(Fig.19-d). The slight difference in porosity after six hours of culture between control and 
HUV/MDA is not clear on the histology images at this magnification (Fig19-a, b). 
Mainly, the control images seem to have darker coloration than the HUV/MDA construct, 
which potentially shows no significant difference regarding the cell quantification present 
on those scaffolds. 
Figure 20 is composed by the histology images of the control and HUV/MDA construct 
after 10 days of culture at x10 magnification. The difference of porosity observed 
previously between the control and HUV/MDA construct after six hours is more evident 
at this magnification (Fig19-a, b), the fiber also appears more aligned and organized on 
the control after six hours (Fig.20-a). Over the course of the experiment, the HUV/MDA 
construct’s porosity observed on the histology images (Fig.20-b, d, f, h) seemed to 
increase, but it is not verified statistically in Table 1. There is still no clear evidence of 
presence of cells at this magnification or at any greater magnification. 
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Figure 19: Histology Images MDA seeded construct Day 1 – 10 at 4x magnification. 
Cross-sectional views of the tissue samples. Scale bar is 200 µm. a – 6 hour non-seeded 
HUV controls, b – 6 hour seeded HUV samples, c – 2 day non-seeded HUV controls, d – 
2 day seeded HUV samples, e – 6 day non-seeded HUV controls, f – 6 day seeded HUV 
samples, g – 10 day non-seeded HUV controls, h – 10 day seeded HUV samples. 
  
a     b 
 
 
c     d 
 
 
e     f 
 
 
g     h 
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Figure 20: Histology Images MDA seeded construct Day 1 – 10 at 10x magnification. 
Cross-sectional views of the tissue samples. Scale bar is 200 µm. a – 6 hour non-seeded 
HUV controls, b – 6 hour seeded HUV samples, c – 2 day non-seeded HUV controls, d – 
2 day seeded HUV samples, e – 6 day non-seeded HUV controls, f – 6 day seeded HUV 
samples, g – 10 day non-seeded HUV controls, h – 10 day seeded HUV samples. 
a     b 
 
 
c     d 
 
 
e     f 
 
 
g     h 
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3.2.2.2 PC3 experiment 
Table 2 represents the porosity of both control and HUV/PC3 construct after 10 days of 
culture. The control porosity is relatively constant except after six days of culture. On the 
opposite, the HUV/PC3 construct’s porosity seems to slightly increase over time. 
 6	HOURS	 2	DAYS	 6	DAYS	 10	DAYS	
CONTROL	 39.0%	± 8.19	 39.3%	± 0.54	 44.9%	± 0.82	 38.74%	± 2.72	
HUV/PC3	 37.6%	± 1.93	 44.2%	± 2.33	 43.5%	± 3.75	 46.84%	± 3.1 
 
Table 2: Porosity of control and HUV/PC3 construct. 
 
Coupling those results to Figure 21, which shows the histology images of the control and 
HUV/PC3 construct at x4 magnification corresponding, the control sample after six days 
of culture (Fig.21-e) seems lighter than the other control samples. There is no significant 
increase of porosity on the HUV/PC3 construct (Fig.21-b, d, f, h) at this magnification. 
The control samples do not seem more organized and fibers more aligned than for the 
HUV/PC3 construct.  
Figure 22 is composed by the histology images of the control and HUV/PC3 construct 
after 10 days of culture at x10 magnification. The porosity increases of the HUV/PC3 
construct (Fig.22-b, d, f, h) is more evident at this magnification. There is no evidence of 
presence of cells on any scaffolds. 
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Figure 21: Histology Images PC3 seeded construct Day 1 – 10 at 4x magnification. 
Cross-sectional views of the tissue samples. Scale bar is 200 µm. a – 6 hour non-seeded 
HUV controls, b – 6 hour seeded HUV samples, c – 2 day non-seeded HUV controls, d – 
2 day seeded HUV samples, e – 6 day non-seeded HUV controls, f – 6 day seeded HUV 
samples, g – 10 day non-seeded HUV controls, h – 10 day seeded HUV samples. 
a     b 
 
 
c     d 
 
 
e     f 
 
 
g     h 
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Figure 22: Histology Images PC3 seeded construct Day 1 – 10 at 10x magnification. 
Cross-sectional views of the tissue samples. Scale bar is 200 µm. a – 6 hour non-seeded 
HUV controls, b – 6 hour seeded HUV samples, c – 2 day non-seeded HUV controls, d – 
2 day seeded HUV samples, e – 6 day non-seeded HUV controls, f – 6 day seeded HUV 
samples, g – 10 day non-seeded HUV controls, h – 10 day seeded HUV samples. 
a     b 
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g     h 
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3.2.2.3 Fresh and decellularized HUV 
The fresh HUV’s porosity has been roughly established at 49.6%±1.39 compared to 
62.2%±1.37 for a decellularized HUV. It is hypothesized that the agents used during the 
decellularization modify the structure of the scaffold. 
Figure 23 represents the histology images of a fresh and decellularized HUV on the 
Wharton’s jelly side. The fibers are aligned and the network seemed organized in both 
samples. There is no evidence of any cell presence on the fresh cord or removed on the 
decellularized one. 
 
 
 
 
 
 
 
Figure 23: Histology Images of decellularization process. 
Cross-sectional views of the tissue samples at 4x magnification. a – Images of Fresh 
HUV, b –  Decellularized HUV at x4 magnification.  
3.2.2.4 Summary of cell-tissue attachment histology images and porosity analysis 
The porosities of the MDA and PC3 constructs are similar and close to the porosity of the 
fresh and plain decellularized HUV. The histology pictures show a general idea of a more 
organized and aligned fiber network on the MDA control images than on the HUV/MDA 
construct’s one. The decellularized and fresh HUV doesn’t demonstrate a porosity 
difference. The organization and fiber alignment network is conserved and there is no 
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evidence of any cell removal during the decellularization process on those histology 
images. 
 Seeding and culturing on non-decellularized construct 
 DNA Assay 
The amount of DNA has been studied for the Wharton’s Jelly/MDA construct and for the 
Wharton’s Jelly/PC3 construct over a period of six days to observe the DNA evolution of 
the different constructs. It is good to remember as enounced in section §2.6.3 that the 
amount of DNA measured in those experiments can be associated with a quantity of cells 
via: 
QuantityQH	RST	UG	DGF	VFLL	 µg = Quantity		of	cells		×	QuantityQHRST	UG	HIJKLF	(pg/cell)10O  
 
The p-values have been established according to a one-way ANOVA with post-hoc 
Tukey HSD test. After 48 hours of culture, the fresh Wharton’s jelly pieces have been 
estimated containing 1.55 ± 0.083µg of DNA. 
3.3.1.1 MDA 
Figure 24 shows the amount of DNA present on the cultured-scaffold construct, 
(Wharton’s Jelly cultured for 48 hours in order to amplify the amount of Wharton’s Jelly 
cells present on the construct (described in section §2.5.1)), seeded with MDA as a 
function of a duration for six days. The amount of DNA measured for the Wharton’s 
Jelly/MDA remain constant and under the dashed line representing the amount of DNA 
seeded (originally cells seeded) on top of the cultured-scaffold during the entire 
experiment. On the contrary, the amount of DNA measured for the cultured-scaffold 
decreases after two days of the experiment. Those two different scaffolds are statistically 
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different after six hours and two days of experiment. This demonstrates that the MDAs 
seeded don’t proliferate on top of the cultured-scaffold and the Wharton’ Jelly cells don’t 
proliferate under the parameters of culture of this experiment. In addition, the amount of 
DNA measured from the Wharton’s Jelly/MDA construct is significantly lower after two 
and six days of culture than the amount of DNA measured from the MDA culture in a 6-
well plate. This last one increases exponentially over the time of the experiment. This 
confirms that the MDAs added on top of the cultured-scaffold don’t proliferate where 
they have been seeded on. 
Consequently, there is no significant cell adhesion or cell proliferation for the Wharton’s 
Jelly/MDA construct or the cultured-scaffold. This matrix and parameters of culture 
doesn’t give the network and proper conditions for MDAs attachment and proliferation. 
 
Figure 24: Cultured-scaffold seeded with MDA Day 1 – 6. 
DNA content of Wharton’s Jelly/MDA (which stands for the cultured-scaffold seeded 
with MDA) as a function of the duration. * indicates p-value<0.05 and ** indicates p-
value<0.01 compared to the cultured-scaffold at each time. Data represented as mean ± 
standard deviation. A sample size of n = 3 was used. Dashed line indicates initial seeding 
density of about 70,000 cells / g of tissue or about 0.52µg of DNA. 
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3.3.1.2 PC3 
Figure 25 shows the amount of DNA present with the cultured-scaffold (Wharton’s Jelly 
cultured for 48 hours in order to amplify the amount of Wharton’s Jelly cells present on 
the construct (described in section §2.5.1)), seeded with PC3 as a function of a duration 
for six days. The amount of DNA decreases after two days of culture and increases back 
after six days of culture for the seeded Wharton’s Jelly and over the dashed line 
representing the amount of DNA seeded (originally cells seeded) on top of the cultured-
scaffold during the entire experiment. On the other hand, the amount of DNA measured 
for the cultured-scaffold decreases over the time of the experiment. Those two different 
scaffolds are statistically different after six days of experiment. Those observations 
demonstrate that some of the PC3s seeded on top of the cultured-scaffold adhered after 
two days of culture and start proliferating after six days, and the Wharton’ Jelly cells 
don’t proliferate under the parameters of culture of this experiment. In addition, the 
amount of DNA measured from the Wharton’s Jelly/PC3 construct is statistically 
different at any time of culture compared to the amount of DNA measured from the PC3 
culture in a 6-well plate. This shows that the cells don’t proliferate as well as when 
cultured in a 6-well plate. 
Consequently, it is observed that this matrix and conditions of the culture give a necessary 
network and conditions for a moderate cell adhesion and proliferation of PC3s seeded on 
top of a cultured-scaffold (cell growth still appears much lower than the PC3 culture in 
6-well plate). 
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Figure 25: Cultured-scaffold seeded with PC3 Day 1 – 6. 
DNA content of Wharton’s Jelly/PC3 (which stands for the cultured-scaffold seeded with 
PC3) as a function of the duration. ** indicates p-value<0.01 compared to the cultured-
scaffold at each time. Data represented as mean ± standard deviation. A sample size of n 
= 3 was used. Dashed line indicates initial seeding density of about 110,000 cells / g of 
tissue or about 0.4µg of DNA. 
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4. Conclusion 
The studies presented above have shown different aspects of the decellularized HUV and 
decellularized HUV/cancer cells constructs, as well as some aspects of the fresh 
Wharton’s jelly pieces and Wharton’s jelly/cancer cells constructs.  
First, the cell-tissue attachment was studied via DNA assays and histology images 
coupled with a rough estimation of porosity. Analyzing the DNA assays, both the six or 
10-day experiments on both cell lines showed a high quantity of DNA measured after six 
hours of incubation on the decellularized scaffold. This demonstrates a contamination 
coming from the decellularized cord storage process. It was then necessary to verify that 
the decellularization process has been conducted properly. The decellularized cords are 
at 15.43 ± 4.266µg DNA / g of dry tissue, which is under the limit established by 
McFetridge et al. to be considered decellularized properly. Looking more precisely to 
each steps of this process, the storage in the PBS in the fridge has increased the quantity 
of DNA from after the water bath at 0.4 ± 0.03µg DNA / g of dry tissue to 15.43 ± 4.266. 
Consequently, further analysis on any cell-tissue attachment wasn’t been possible. It is 
hypothesized that the contamination is coming from a bacterial or fungal development 
when the PBS solutions have been stored in the fridge. In order to have a complete 
analysis of the elements in the experiment, the impact of the Pizzabox on the cellularity 
was studied. The Pizzabox slows the cell proliferation after six days of culture. Further 
studies are necessary, but it seems that the Pizzabox was not responsible for the non-cell 
proliferation of the experiment. It is not clear that either the dye from the PLA used to 
build the Pizzabox is responsible or the friction with the bottom of the well is responsible. 
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The observations of histology images show that the porosity and organized network of 
the HUV remain the same after decellularization and that the chemicals used in the 
process don’t change the matrix properties. No cells were observed on any scaffold and 
at any time, which highly reinforced the bacterial or fungi contamination suspected. 
Second, the seeding on a non-decellularized construct was studied with DNA assay only. 
Both cultured-scaffolds (Wharton’s Jelly cultured for 48 hours prior both MDA and PC3 
experiments) show a decreased amount of DNA and a decreased amount of cellularity 
over the time of culture. While the Wharton’s Jelly/MDA seeded, construct has not 
demonstrated any cell development (defined by any increase of amount of DNA); the 
Wharton’s Jelly/PC3 seeded construct possessed a development. The amount of DNA 
detected has always been superior to the amount of DNA seeded (or cells seeded) and 
increased after six days of culture.  
This preliminary study could then show a Wharton’s Jelly cells - PC3 attachment and 
possibly a cell proliferation if studied with a longer culture period.  
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5. Future directions 
Even though the decellularized HUV cellularity is under 50µg DNA / g of dry tissue, a 
deeper study would need to be conducted to identify what is detected on the dsDNA 
quantification more precisely, especially after the storage solution step. It is hypothesized 
that it is bacterial or fungi DNA and this storage solution needs to be improved or deleted 
from the process. The Pizzabox slowed the cellularity of the two cancer cell lines of this 
study. In order to solve this issue in future studies, there might be a different Makerbot 
filament (material used by the 3D printer utilized in this experiment) with different 
properties, which would not affect cell cultures, or another Pizzabox could be built with 
a stainless material, which has already shown effectiveness on cell culture. The weight of 
this piece needs to be carefully observed in order to keep the ECM properties of the 
scaffolds. The study of the cell-tissue attachment would be then properly designed and 
could be conducted first over two days of experiment in order to study the cell attachment 
and further on a 10-days experiment to see if the cancer cells are able to develop on this 
matrix. 
The seeding on a non-decellularized construct demonstrated more promise, especially for 
the PC3 cell line. Longer culture times should be conducted to confirm those results and 
different cell lines could be tested to verify the matrix compatibility.  
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Appendix A: List of Acronyms 
 
ATCC American Type Culture Collection 
DI Distilled water 
ECM Extra-cellular matrix 
FBS Fetal Bovine Serum 
HA Hyaluronic Acid 
HUC Human Umbilical Cord 
HUV Human Umbilical Vein 
HUVECs Human Umbilical Vein Endothelial Cells  
MCTs Multicellular tumor spheroids (MCTs) 
NCI National Cancer Institute 
PBS Phosphate Buffer Saline 
PLA Poly-lactic-L-Acid 
PPE Personal Protective Equipment 
rcf Relative Centrifugal Force 
SDS Sodium Dodecyl Phosphate 
vol Volume 
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Appendix B: Preparation of PBS for vein decellularization 
 
• PBS has the same concentration of salts as cells. Thus, by washing the cells with 
it instead of water we prevent osmosis 
 
 
Supplies  
• Sodium Phosphate Monobasic Monohydrate 𝑁𝐴𝐻#𝑃𝑂`𝐻#𝑂  
• Sodium Phosphate Dibasic Anhydrous 𝑁𝐴𝐻#𝑃𝑂` 
• Beaker 
 
Protocol  
 
1. Quantity prepare a total of 1000ml of PBS @ 150mM and PH=7.4 
2. Put Beaker on magnetic stirrer and place magnet inside beaker 
3. Add about 800mL of distilled water 
4. Turn stir to about 6 
5. Add 3.94 g Monobasic Monohydrate 𝑁𝐴𝐻#𝑃𝑂`𝐻#𝑂  
6. Wash boat with extra 100 ml of water 
7. Add 16.77 g Dibasic Anhydrous 𝑁𝐴𝐻#𝑃𝑂` 
8. Wash weighing boat with the remaining 100 ml of water 
9. Pour PBS in bottle and autoclave 
 
 
 
 
 
 
  
60 
Appendix C: Paraffin embedment protocol  
 
• If a step is done repeatedly, use new solution each time  
• Glass vials work well to hold solutions  
• Use 95% ethanol to make diluted ethanol solutions  
• Make sure 100% ethanol is sealed well to maintain purity  
 
Supplies  
• Glass vials  
• 95% Ethanol  
• 100% Ethanol  
• Formalin  
• Clear Rite 3  
• Paraffin  
• Molds  
• Cassettes  
 
Protocol  
 
1. Place tissue in 10% Formalin for 1 hour  
a. If not processing immediately, leave tissue in formalin overnight and store in 
refrigerator in 70% ethanol for long term storage  
2. Place tissue in 85% ethanol for 1 hour  
3. Place tissue in 95% ethanol for 1 hour  
4. Place tissue in 95% ethanol for 1 hour  
5. Place tissue in 100% ethanol for 45 minutes  
6. Place tissue in 100% ethanol for 45 minutes  
7. Place tissue in 100% ethanol for 45 minutes  
8. Place tissue in Clear Rite 3 for 1 hour at 45oC  
9. Place tissue in Clear Rite 3 for 1 hour at 45oC  
10. If not already in a cassette, place tissue in cassette  
11. Place tissue in Paraffin for 2 hours at 60oC in heated vacuum chamber in D211  
a. Stir every half hour to ensure mixing and thorough penetration of paraffin  
12. To prepare for embedding, place a small layer of melted paraffin in mold and allow 
to stiffen, but not completely harden  
13. Take tissue out of paraffin bath and cassette. Place tissue in desired orientation in the 
mold, using the stiff paraffin to hold it.  
14. Fill mold with paraffin  
15. Place cassette base in mold securely  
16. Let sample cool and section with a microtome (7μm thick)  
17. Place at 60 °C for 24 hours. The sample is ready for staining.  
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Appendix D: Hematoxylin and eosin staining protocol 
 
Supplies  
• Histology jars (containing 200-250 ml of solution)  
• Glass slide holders  
• Clear Rite  
• Clear Rite/Ethanol 50/50 solution  
• 100% Ethanol  
• 95% Ethanol  
• DI Water  
• Tap Water  
• Hematoxylin  
• Eosin  
• Mounting Medium  
• Coverslips  
• Chemwipes  
 
Protocol  
1. Clear Rite 3 for 3 minutes  
2. Clear Rite 3 for 3 minutes  
3. Clear Rite 3 for 3 minutes  
4. Clear Rite/Ethanol 50/50 solution for 1 minute  
5. 100% ethanol for 1 minute  
6. 23. 95% ethanol for 1 minute  
7. 24. 85% ethanol (made from 95% ethanol) for 1 minute  
8. 75% ethanol (made from 95% ethanol) for 1 minute  
9. DI Water for 1 minute  
10. Hematoxylin for 5 minutes  
11. Tap Water Rinse for 1 minute  
12. Eosin for 1 minute  
13. DI Water rinse for 1 minute  
14. 95% ethanol for 1 minute  
15. 95% ethanol for 1 minute  
16. 100% ethanol for 1 minute  
17. 100% ethanol for 1 minute  
18. Clear Rite/Ethanol 50/50 solution for 1 minute  
19. Clear Rite 3 for 1 minute  
20. Clear Rite 3 for 1 minute  
21. Blot away excess clear rite 3 with chemwipe  
22. Place a drop of mounting medium on sample  
23. Place coverslip on slide  
